ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is one of the 10 biotech stocks screaming a buy. On June 17, the company moved to ...

In the preceding three months, 13 analysts have released ratings for ACADIA Pharmaceuticals ACAD, presenting a wide array of ...

Investing.com - RBC Capital raised its price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $38.00 from $26.00 on Monday, while maintaining an Outperform rating on the stock.The company ...